Moreover, the treatment of MM cells with bortezomib decreased the expression of Sp1 with the consequent increase of miR-29b level, indicating that this miRNA can be regulated not only by c-Myc but also by Sp1 [75]. Here, MYC is linked to Miyoshi myopathy.